Literature DB >> 22049233

Blood pressure regulation in diabetic patients with and without peripheral neuropathy.

Siqi Wang1, David C Randall, Charles F Knapp, Abhijit R Patwardhan, Kevin R Nelson, Dennis G Karounos, Joyce M Evans.   

Abstract

Cardiac and vascular dysfunctions resulting from autonomic neuropathy (AN) are complications of diabetes, often undiagnosed. Our objectives were to: 1) determine sympathetic and parasympathetic components of compromised blood pressure (BP) regulation in patients with peripheral neuropathy and 2) rank noninvasive indexes for their sensitivity in diagnosing AN. We continuously measured electrocardiogram, arterial BP, and respiration during supine rest and 70° head-up tilt in 12 able-bodied subjects, 7 diabetics without, 7 diabetics with possible, and 8 diabetics with definite, sensory, and/or motor neuropathy (D2). During the first 3 min of tilt, systolic BP (SBP) of D2 decreased [-10.9 ± 4.5 (SE) mmHg] but increased in able-bodied (+4.8 ± 5.4 mmHg). Compared with able-bodied, D2 had smaller low-frequency (0.04-0.15 Hz) spectral power of diastolic BP, lower baroreflex effectiveness index (BEI), and more SBP ramps. Except for low-frequency power of SBP, D2 had greater SBP and smaller RR interval harmonic and nonharmonic components at rest across the 0.003- to 0.45-Hz region. In addition, our results support previous findings of smaller HF RR interval power, smaller numbers of baroreflex sequences, and lower baroreflex sensitivity in D2. We conclude that diabetic peripheral neuropathy is accompanied by diminished parasympathetic and sympathetic control of heart rate and peripheral vasomotion and diminished baroreflex regulation. A novel finding of this study lies in the sensitivity of BEI to detect AN, presumably because of its combination of parameters that measure reductions in both sympathetic control of vasomotion and parasympathetic control of heart rate.

Entities:  

Mesh:

Year:  2011        PMID: 22049233      PMCID: PMC3311521          DOI: 10.1152/ajpregu.00174.2011

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  57 in total

1.  Baroreflex effectiveness index: an additional measure of baroreflex control of heart rate in daily life.

Authors:  M Di Rienzo; G Parati; P Castiglioni; R Tordi; G Mancia; A Pedotti
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-03       Impact factor: 3.619

Review 2.  Fractal characterization of complexity in temporal physiological signals.

Authors:  A Eke; P Herman; L Kocsis; L R Kozak
Journal:  Physiol Meas       Date:  2002-02       Impact factor: 2.833

3.  Power-law behavior of heart rate variability in Chagas' disease.

Authors:  Antonio Luiz P Ribeiro; Federico Lombardi; Marcos Roberto Sousa; Marcio Vinicius Lins Barros; Alberto Porta; Vladimir Costa Val Barros; Murilo E D Gomes; Fernando Santana Machado; Manoel Otávio Costa Rocha
Journal:  Am J Cardiol       Date:  2002-02-15       Impact factor: 2.778

Review 4.  Diabetic autonomic neuropathy.

Authors:  Aaron I Vinik; Raelene E Maser; Braxton D Mitchell; Roy Freeman
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112

5.  Differential effect of head-up tilt on cardiovagal and sympathetic baroreflex sensitivity in humans.

Authors:  D D O'Leary; D S Kimmerly; A D Cechetto; J K Shoemaker
Journal:  Exp Physiol       Date:  2003-11       Impact factor: 2.969

Review 6.  Recognizing and treating diabetic autonomic neuropathy.

Authors:  A I Vinik; T Erbas
Journal:  Cleve Clin J Med       Date:  2001-11       Impact factor: 2.321

7.  Characteristics of aortic diastolic pressure decay with application to the continuous monitoring of changes in peripheral vascular resistance.

Authors:  M J Bourgeois; B K Gilbert; D E Donald; E H Wood
Journal:  Circ Res       Date:  1974-07       Impact factor: 17.367

8.  Epinephrine, vasodilation and hemoconcentration in syncopal, healthy men and women.

Authors:  J M Evans; F M Leonelli; M G Ziegler; C M McIntosh; A R Patwardhan; A C Ertl; C S Kim; C F Knapp
Journal:  Auton Neurosci       Date:  2001-10-08       Impact factor: 3.145

9.  Time- and frequency-domain estimation of early diabetic cardiovascular autonomic neuropathy.

Authors:  D Ziegler; D Laude; F Akila; J L Elghozi
Journal:  Clin Auton Res       Date:  2001-12       Impact factor: 4.435

10.  Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale.

Authors:  G Cavaletti; G Bogliun; L Marzorati; A Zincone; M Piatti; N Colombo; G Parma; A Lissoni; F Fei; S Cundari; C Zanna
Journal:  Neurology       Date:  2003-11-11       Impact factor: 9.910

View more
  4 in total

1.  Baroreflex control of renal sympathetic nerve activity in early heart failure assessed by the sequence method.

Authors:  Renata Maria Lataro; Luiz Eduardo Virgilio Silva; Carlos Alberto Aguiar Silva; Helio Cesar Salgado; Rubens Fazan
Journal:  J Physiol       Date:  2017-04-07       Impact factor: 5.182

2.  Extended longitudinal analysis of arterial pressure and heart rate control in unanesthetized rats with type 1 diabetes.

Authors:  Chikodi N Anigbogu; Richard O Speakman; Dennis L Silcox; Laura V Brown; David R Brown; Ming C Gong; Abhijit R Patwardhan; L Raymond Reynolds; Dennis G Karounos; Don E Burgess; Bobby R Baldridge; David C Randall
Journal:  Auton Neurosci       Date:  2012-07-17       Impact factor: 3.145

3.  Cardiovascular autonomic responses during head-up tilt test in newly diagnosed type 2 diabetes.

Authors:  Esteban Jorge-Galarza; Margarita Torres-Tamayo; María Del Rocío Martínez-Alvarado; Berenice Peña-Aparicio; Carmen González-Salazar; Juan Reyes-Barrera; Manuel Sierra-Beltrán; Erika Fajardo-Flores; Andrey Kostin; J Antonio González-Hermosillo
Journal:  Ir J Med Sci       Date:  2021-11-08       Impact factor: 2.089

4.  Variability of peripheral pulse wave velocity in patients with diabetes mellitus type 2 during orthostatic challenge.

Authors:  J Svačinová; J Hrušková; J Jakubík; K Budinskaya; S Hidegová; M Fabšík; H Sieglová; Z Kaščáková; J Novák; Z Nováková
Journal:  Physiol Res       Date:  2020-12-31       Impact factor: 1.881

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.